Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02ZCM
|
|||
| Former ID |
DNCL003178
|
|||
| Drug Name |
Ad26.ENVA.01 HIV-1 recombinant vaccine
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1 | [1] | |
| Company |
Crucell
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00618605) Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.